Rizqiya Astri Hapsari
Research Subjects
Rizqiya Astri Hapsari has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Alfi Khatib
Department of Pharmaceutical Chemistry, Kulliyyah of Pharmacy, International Islamic University Malaysia, Kuantan, Malaysia
1 shared publication - Anastasia Fitria Devi
Research Center for Chemistry, National Research and Innovation Agency (BRIN) Republic of Indonesia, Kawasan Puspiptek, Tangerang Selatan 15314, Indonesia
1 shared publication - Berna Elya
Faculty of Pharmacy, Universitas Indonesia, Depok 16424, West Java, Indonesia
1 shared publication - Husniati Husniati
Department of Pharmacognosy and Phytochemistry, Faculty of Pharmacy, Universitas Indonesia, Depok 16424, Indonesia
1 shared publication - Muhammad Hanafi
3) Research Center for Pharmaceutical Ingredients and Traditional Medicine, National Research and Innovation Agency (BRIN), Serpong. 15314, Indonesia. 4) Department of Phytochemistry, Faculty of Pharmacy, Pancasila University, South Jakarta, 12640
1 shared publication - Nina Artanti
Research Center for Chemistry, National Research and Innovation Agency (BRIN), Tangerang Selatan 15314, Banten, Indonesia
1 shared publication
Latest Publications
- Open Access
- 15 November 2025
- Published by Pandawa Institute in Journal of Multidisciplinary Applied Natural Science
- Vol. 6 (1) , 304-325
Identification of Potential Antioxidant and Antidiabetic α-Glucosidase Inhibitors from Pometia pinnata Through In Vitro, Metabolite Profiling, and Molecular Docking
Oxidative stress induced by reactive oxygen species is critical in the progressing of type 2 diabetes mellitus. Thus, early intervention using plant-derived secondary metabolites with antioxidant and α-glucosidase inhibitory (AGI) activities is essential for adequate glycemic control. Pometia pinnata has demonstrated antidiabetic potential, though scientific evidence remains limited. This study aimed to determine the in vitro antioxidant and AGI activities of P. pinnata extracts (fruit peel, root bark, and stem bark). Metabolites from selected stem bark extracts were identified via LC-HRMS and further validated through molecular docking. Sequential maceration using n-hexane, ethyl acetate, methanol, and water was employed to obtain extracts. Ethyl acetate extracts of stem and root bark showed significantly higher total phenolic and flavonoid contents with higher antioxidant activity than other solvent extracts. The stem bark extract yielded the highest compound content (2.74%) and AGI activity (62.78 ± 0.85% inhibition at 15 μg/mL), outperforming the standard drug acarbose (14.66% at the same dose). LC-HRMS profiling of the stem bark extract identified 26 metabolites, with cianidanol exhibiting the strongest binding affinity (ΔG°bind = –7.63 kcal/mol) in molecular docking, surpassing acarbose (–2.51 kcal/mol). These findings confirm the presence of bioactive compounds in P. pinnata that contribute to α-glucosidase inhibition and are correlated with antioxidant capacity.
- 15 November 2025
- Published by Pandawa Institute in Journal of Multidisciplinary Applied Natural Science
- Vol. 6 (1) , 304-325
Open AccessIdentification of Potential Antioxidant and Antidiabetic α-Glucosidase Inhibitors from Pometia pinnata Through In Vitro, Metabolite Profiling, and Molecular Docking
Oxidative stress induced by reactive oxygen species is critical in the progressing of type 2 diabetes mellitus. Thus, early intervention using plant-derived secondary metabolites with antioxidant and α-glucosidase inhibitory (AGI) activities is essential for adequate glycemic control. Pometia pinnata has demonstrated antidiabetic potential, though scientific evidence remains limited. This study aimed to determine the in vitro antioxidant and AGI activities of P. pinnata extracts (fruit peel, root bark, and stem bark). Metabolites from selected stem bark extracts were identified via LC-HRMS and further validated through molecular docking. Sequential maceration using n-hexane, ethyl acetate, methanol, and water was employed to obtain extracts. Ethyl acetate extracts of stem and root bark showed significantly higher total phenolic and flavonoid contents with higher antioxidant activity than other solvent extracts. The stem bark extract yielded the highest compound content (2.74%) and AGI activity (62.78 ± 0.85% inhibition at 15 μg/mL), outperforming the standard drug acarbose (14.66% at the same dose). LC-HRMS profiling of the stem bark extract identified 26 metabolites, with cianidanol exhibiting the strongest binding affinity (ΔG°bind = –7.63 kcal/mol) in molecular docking, surpassing acarbose (–2.51 kcal/mol). These findings confirm the presence of bioactive compounds in P. pinnata that contribute to α-glucosidase inhibition and are correlated with antioxidant capacity.